Low cholesteryl ester transfer protein and phospholipid transfer protein activities are the factors making tree shrew and Beijing duck resistant to atherosclerosis

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Liu, Hui Rong ^a   Wu, Gang ^b   Zhou, Bing ^c   Chen, Bao Sheng ^b  

^a INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c Beijing Center for ADR Monitoring   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL; CETP PROTEIN, HUMAN; CHOLESTEROL;

ADULT; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DISEASE RESISTANCE; DUCK; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCANDENTIA; SPECIES COMPARISON; SPECIES DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; ENZYMOLOGY;

ANAS PLATYRHYNCHOS; ANIMALIA; TUPAIIDAE;

ADULT; ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DUCKS; HUMANS; MALE; PHOSPHOLIPID TRANSFER PROTEINS; TUPAIIDAE; YOUNG ADULT;

EID: 77957730710     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-114     Document Type: Article

References (31)

1. Lipid transfer proteins: past, present and perspectives. EC Quinto PM Cazita, Atherosclerosis 2010 209 1 9 10.1016/j.atherosclerosis.2009.08.002 19733354
2. The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. D Masson XC Jiang L Lagrost AR Tall, J Lipid Res 2009 50 201 206 10.1194/jlr.R800061-JLR200 19023137
3. Specificity of lecithin:cholesterol acyltransferase and atherogenic risk: comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species. M Liu JD Bagdade PV Subbaiah, J Lipid Res 1995 36 1813 1824 7595102
4. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. V Guyard-Dangremont C Desrumaux P Gambert C Lallemant L Lagrost, Comp Biochem Physiol B Biochem Mol Biol 1998 120 517 525 10.1016/S0305-0491(98)10038-X 9787811
5. The role of a-lipoprotein in preventing atheromatous plaques developed in tree shrew assoxiating with induced hypercholesterinemia. MP She YZ Lu RY Xia ZL Wang SH Lv WM An SM Zhao LS Liu PM Liu SM Guo P Liang BW Tao, ZhongHuaYaoLiXueZaZhi 1982 11 23 28
6. The differences of serum cholesterol and lipoproteins in animals susceptible and nonsusceptible to atherosclerosis. KQ Wang ZG Li QL Hao JL He XZ Li HZ Zhang JJ Tang G Wu BS Chen JM Wang H Xue YM Hu, Proc Chin Acad Med Sci Peking Union Med Coll 1990 5 112 119 2123036
7. Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries. SJ Nicholls, Curr Opin Lipidol 2009 20 491 496 10.1097/MOL.0b013e32832ec396 19593124
8. Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels. DJ Hausenloy DM Yellon, Curr Opin Cardiol 2009 24 473 482 10.1097/HCO.0b013e32832ebfe7 19574922
9. Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease. JJ Badimán B Ib̃ez, Rev Esp Cardiol 2010 63 323 333 20196993
10. The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. K Tsutsumi A Hagi Y Inoue, Biol Pharm Bull 2001 24 579 581 10.1248/bpb.24.579 11379785
11. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. ML Brown A Inazu CB Hesler LB Agellon C Mann ME Whitlock YL Marcel RW Milne J Koizumi H Mabuchi, Nature 1989 342 448 451 10.1038/342448a0 2586614
12. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. A Inazu ML Brown CB Hesler LB Agellon J Koizumi K Takata Y Maruhama H Mabuchi AR Tall, N Engl J Med 1990 323 1234 1238 10.1056/NEJM199011013231803 2215607
13. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. A Thompson E Di Angelantonio N Sarwar S Erqou D Saleheen RP Dullaart B Keavney Z Ye J Danesh, JAMA 2008 299 2777 2788 10.1001/jama.299.23.2777 18560005
14. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. AS Plump L Masucci-Magoulas C Bruce CL Bisgaier JL Breslow AR Tall, Arterioscler Thromb Vasc Biol 1999 19 1105 1110 10195942
15. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. M Westerterp CC van der Hoogt W de Haan EH Offerman GM Dallinga-Thie JW Jukema LM Havekes PC Rensen, Arterioscler Thromb Vasc Biol 2006 26 2552 2559 10.1161/01.ATV. 0000243925.65265.3c 16946130
16. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. MY Tsai C Johnson WH Kao AR Sharrett VL Arends R Kronmal NS Jenny DR Jacobs Jr D Arnett D O'Leary W Post, Atherosclerosis 2008 200 359 367 10.1016/j.atherosclerosis.2007.12.038 18243217
17. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. T Hayek L Masucci-Magoulas X Jiang A Walsh E Rubin JL Breslow AR Tall, J Clin Invest 1995 96 2071 2074 10.1172/JCI118255 7560101
18. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. B Föger M Chase MJ Amar BL Vaisman RD Shamburek B Paigen J Fruchart-Najib JA Paiz CA Koch RF Hoyt HB Brewer Jr S Santamarina-Fojo, J Biol Chem 1999 274 36912 36920 10.1074/jbc.274.52.36912 10601244
19. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis. M Moerland H Samyn T van Gent R van Haperen G Dallinga-Thie F Grosveld A van Tol R de Crom, Arterioscler Thromb Vasc Biol 2008 28 1277 1282 10.1161/ATVBAHA.108.165084 18421000
20. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lie R de Crom T van Gent R van Haperen L Scheek I Lankhuizen A van Tol, J Lipid Res 2002 43 1875 1880 10.1194/jlr.M200166-JLR200 12401886
21. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. R van Haperen A van Tol T van Gent L Scheek P Visser A van der Kamp F Grosveld R de Crom, J Biol Chem 2002 277 48938 48943 10.1074/jbc.M209128200 12372822
22. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J Lie R de Crom T van Gent R van Haperen L Scheek F Sadeghi-Niaraki A van Tol, J Lipid Res 2004 45 805 811 10.1194/jlr.M300487-JLR200 14993244
23. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. XC Jiang AR Tall S Qin M Lin M Schneider F Lalanne V Deckert C Desrumaux A Athias JL Witztum L Lagrost, J Biol Chem 2002 277 31850 31856 10.1074/jbc.M205077200 12105225
24. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. H Samyn M Moerland T van Gent R van Haperen F Grosveld A van Tol R de Crom, Atherosclerosis 2009 204 429 434 10.1016/j.atherosclerosis.2008.10.020 19100548
25. Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study. H Samyn M Moerland T van Gent R van Haperen J Metso F Grosveld M Jauhiainen A van Tol R de Crom, J Lipid Res 2008 49 2504 2512 10.1194/jlr.M800080-JLR200 18711210
26. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. XC Jiang S Qin C Qiao K Kawano M Lin A Skold X Xiao AR Tall, Nat Med 2001 7 847 752 10.1038/89977 11433351
27. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. T Hayek N Azrolan RB Verdery A Walsh T Chajek-Shaul LB Agellon AR Tall JL Breslow, J Clin Invest 1993 92 1143 1152 10.1172/JCI116683 8376576
28. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. B Föger S Santamarina-Fojo RD Shamburek CL Parrot GD Talley HB Brewer Jr, J Biol Chem 1997 272 27393 27400 10.1074/jbc.272.43.27393 9341191
29. Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism. M Moerland N Anghelescu H Samyn R van Haperen T van Gent J Strouboulis A van Tol F Grosveld R de Crom, Transgenic Res 2007 16 503 513 10.1007/s11248-007-9094-y 17437182
30. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. XP Yang D Yan C Qiao RJ Liu JG Chen J Li M Schneider L Lagrost X Xiao XC Jiang, Arterioscler Thromb Vasc Biol 2003 23 1601 1607 10.1161/01.ATV.0000085841.55248.13 12855484
31. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. XC Jiang Z Li R Liu XP Yang M Pan L Lagrost EA Fisher KJ Williams, J Biol Chem 2005 280 18336 18340 10.1074/jbc.M500007200 15734742